Target intelligence / Profile preview

Pathogenic skin bacterium

Molecular classification
Other (in context, refers to groups of bacteria)
01

Overview

Pathogenic skin bacteria represent a broad array of bacterial species that can infect the skin, leading to conditions ranging from minor superficial infections such as impetigo and folliculitis to severe deep infections such as cellulitis, abscesses, and necrotizing fasciitis. The most common pathogenic skin bacteria are Staphylococcus aureus (including MRSA) and Streptococcus pyogenes, but others such as Corynebacterium minutissimum, Pseudomonas aeruginosa, and mycobacteria can also cause skin disease. These organisms may be part of the normal microbiota but can become pathogenic when barriers are breached or the immune system is compromised. Treatment depends on the causative organism and resistance profile, and antibiotic resistance is an increasing concern[1][2][3][4][5][6].

Other names
Pathogenic cutaneous bacteriaskin infection-causing bacteriapathogenic skin microbes
02

Mechanism of action

Inhibition of cell wall synthesis (e.g., beta-lactams); Inhibition of protein synthesis (e.g., tetracyclines, clindamycin); Disruption of nucleic acid synthesis (e.g., fluoroquinolones); Disruption of bacterial membranes (e.g., polymyxins)

03

Biological functions

InfectionImmune evasionTissue damageOther (depending on the species, e.g., toxin production, local inflammation)
04

Disease associations

InfectionInflammationOther (cellulitis, abscess formation, necrotizing fasciitis, etc.)
05

Safety considerations

Antibiotic resistance (especially MRSA and multi-drug resistant Pseudomonas)Allergic reactions to antibioticsPotential for systemic infection or sepsis in immunocompromised patients
06

Interacting drugs

Antibiotics (e.g., penicillins, cephalosporins, trimethoprim-sulfamethoxazole, clindamycin, doxycycline, vancomycin, linezolid; specific drugs depend on the pathogen and resistance profile)

1 more in the full profile.

07

Biomarkers

Bacterial culture & sensitivityPCR for bacterial DNASpecific proteins or toxins for certain species (e.g., Panton-Valentine leukocidin for S. aureus)

Beyond the preview

Go deeper on Pathogenic skin bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic skin bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call